See All Slides - tctmd.com

Slides

Presentation TCT 2012

No: Changing Standards Would Be Premature!

Presenter: Robert Siegel

October 23, 2012

Presentation TCT 2012

Appropriateness Criteria: Implications for Clinical Practice

Presenter: Monica Losquadro

October 23, 2012

Presentation TCT 2012

PCSK9 Inhibitors: The Holy Grail?

Presenter: Evan Stein

October 23, 2012

Presentation TCT 2012

TCT-67. Impact of Hemodynamic Support with Impella vs. Intraaortic Balloon Counterpulsation on Prognostically Important Ischemic Endpoints: Results from the PROTECT-II Trial

Presenter: George Dangas

October 23, 2012

Presentation TCT 2012

Cre8 (CID) Program Update

Presenter: Didier Carri?

October 23, 2012

Presentation TCT 2012

Subcutaneous Defibrillators

Presenter: Gust Bardy

October 23, 2012

Presentation TCT 2012

TCT-100. Transcatheter Aortic Valve Replacement for Degenerative Bioprosthetic Surgical Valves: Results from the Global Valve-in-Valve Registry

Presenter: Danny Dvir

October 23, 2012

Presentation TCT 2012

How to Become Trained and Start a LAA Closure Program

Presenter: Brian Whisenant

October 23, 2012

Presentation TCT 2012

TCT-6. Biodegradable Polymer-based Biolimus A9-eluting Stent for the Treatment of Infrapopliteal Arteries in Critical Limb Ischemia: Long-term Clinical and Angiographic Follow-up

Presenter: Eugenio Stabile

October 23, 2012

Presentation TCT 2012

TCT-84. Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients 75 Years or Greater; A Sub-Analysis of the PROTECT AF Study

Presenter: Saibal Kar

October 23, 2012

Advertisement

Slides

No: Changing Standards Would Be Premature!

Appropriateness Criteria: Implications for Clinical Practice

PCSK9 Inhibitors: The Holy Grail?

TCT-67. Impact of Hemodynamic Support with Impella vs. Intraaortic Balloon Counterpulsation on Prognostically Important Ischemic Endpoints: Results from the PROTECT-II Trial

Cre8 (CID) Program Update

Subcutaneous Defibrillators

TCT-100. Transcatheter Aortic Valve Replacement for Degenerative Bioprosthetic Surgical Valves: Results from the Global Valve-in-Valve Registry

How to Become Trained and Start a LAA Closure Program

TCT-6. Biodegradable Polymer-based Biolimus A9-eluting Stent for the Treatment of Infrapopliteal Arteries in Critical Limb Ischemia: Long-term Clinical and Angiographic Follow-up

TCT-84. Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients 75 Years or Greater; A Sub-Analysis of the PROTECT AF Study

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content